Second, although the sample size of TCGA-LIHC was relatively large, and the prognostic value of POLD1 was verified using an external validation cohort, further preclinical mechanistic studies and prospective clinical trials are still needed to explore and validate the role of POLD1 in HCC. The gene discussed is POLD1; the disease is hepatocellular carcinoma.